Khiron Gets Kuida® Into Another 150 Stores

Published: May 1, 2019

Khiron Life Sciences Corp., an integrated cannabis company with core operations in Latin America, announced today that it has signed a distribution agreements for its Kuida® cosmeceutical brand with Cafam, a leading Colombian drugstore chain. This agreement further expands the brands points of sales In combination with the previous announced distribution arrangements this agreement further expands the brands retail and e-commerce points of sales in Colombia.

Cafam is a large Colombian conglomerate that is diversified across multiple business lines, with operations built over a 40-year history. Cafam operates 270 stores across 63 different markets in Colombia, generating annual revenue of USD $561M. The Company’s agreement with the drugstore division of Cafam, represents an initial 49 point of sale locations for Kuida®, and an agreement to expand this distribution to a total of 150 stores in the first six months of roll-out of the agreement.

“We continue to see strong demand for the Kuida brand and this agreement with Cafam ensures we can reach more consumers in a convenient point-of purchase environment,” said Mr. Alvaro Torres, CEO and Director of Khiron, “As part of a multi-channel retail distribution strategy, and backed with our comprehensive product training programs this new partnership expands our reach in targeting the $10 Billion Latin American skincare market.”

Kuida®, the first consumer brand of Khiron’s wellness business unit, brings the benefits of cannabidol (CBD) to a comprehensive portfolio of skin and body care products for women. Kuida was launched in Colombia in September 2018 through retail, wholesale and online channels and with an exclusive agreement with Farmatodo, one of Colombia´s largest pharmacy chains with 56 stores.